Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 490-498

  Wu, Nan Lin ^a,b,c,d   Huang, Duen Yi ^c,e   Tsou, Hsin Ni ^c   Lin, Ying Cing ^c   Lin, Wan Wan ^c,e  

^a MACKAY MEDICAL COLLEGE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACT1 ADAPTOR PROTEIN; ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; PROTEIN KINASE SYK; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; CCL20 PROTEIN, HUMAN; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TRAF3IP2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INVESTIGATIVE PROCEDURES; KERATINOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; UBIQUITINATION; UPREGULATION; CELL CULTURE; GENETICS; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; CHEMOKINE CCL20; HUMANS; INTERLEUKIN-17; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE KINASES; NF-KAPPA B; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UBIQUITINATION;

EID: 84925351140     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.383     Document Type: Article

References (53)

1. Ashikawa K, Majumdar S, Banerjee S et al. (2002) Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol 169:6490-7
2. Awane M, Andres PG, Li DJ et al. (1999) NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162:5337-44
3. Battaglia F, Delfino S, Merello E et al. (2008) Hypoxia transcriptionally induces macrophage-inflammatory protein-3alpha/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB. J Leukoc Biol 83:648-62
4. Becher B, Pantelyushin S (2012) Hiding under the skin: Interleukin-17-producing gammadelta T cells go under the skin? Nat Med 18:1748-50
5. Chae S, Eckmann L, Miyamoto Y et al. (2006) Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury. J Immunol 177:1214-20
6. Chang SH, Dong C (2011) Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal 23:1069-75
7. Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M et al. (2011) Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131:677-87
8. Chiu HY, Chen YP, Tsai TF (2012) T helper type 17 in psoriasis: From basic immunology to clinical practice. Dermatol Sinica 30:136-41
9. de Castro DG (2011) Challenges for the implementation of routine molecular diagnostics in cancer care. Expert Rev Mol Diagn 11:549-51
10. Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556-67
11. Garg AV, Ahmed M, Vallejo AN et al. (2013) The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal 6ra44
12. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-60
13. Hamerman JA, Ni MJ, Killebrew JR et al. (2009) The expanding roles of ITAM adapters FcR gamma and DAP12 in myeloid cells. Immunol Rev 232:42-58
14. Harper EG, Guo C, Rizzo H et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175-83
15. Hata K, Andoh A, Shimada M et al. (2002) IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 282:G1035-44
16. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. (2000) Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-32
17. Imaizumi Y, Sugita S, Yamamoto K et al. (2002) Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. Int Immunol 14:147-55
18. Irie T, Muta T, Takeshige K (2000) TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages. FEBS Lett 467:160-4
19. Kanda N, Shibata S, Tada Y et al. (2009) Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39:996-1006
20. Karin M, Delhase M (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12:85-98
21. Laan M, Prause O, Miyamoto M et al. (2003) A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J 21:387-93
22. Lee JH, Lee B, Lee HS et al. (2009) Lactobacillus suntoryeus inhibits proinflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 24:231-7
23. Lin YC, Huang DY, Chu CL et al. (2013) The tyrosine kinase Syk differentially regulates toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3. Sci Signal 6:ra71
24. Liu C, Qian W, Qian Y et al. (2009) Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2:ra63
25. Lu R, Pan H, Shively JE (2012) CEACAM1 negatively regulates IL-1beta production in LPS activated neutrophils by recruiting SHP-1 to a SYK-TLR4-CEACAM1 complex. PLoS Pathog 8:e1002597
26. Meltzer EO, Berkowitz RB, Grossbard EB (2005) An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 115:791-6
27. Mocsai A, Ruland J, Tybulewicz VL (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10:387-402
28. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159:1092-102
29. Okudaira T, Yamamoto K, Kawakami H et al. (2006) Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1. Br J Haematol 132:293-302
30. Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129:311-21
31. Pamuk ON, Tsokos GC (2010) Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases. Arthritis Res Ther 12:222
32. Prause O, Laan M, Lotvall J et al. (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462:193-8
33. Qian Y, Liu C, Hartupee J et al. (2007) The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8:247-56
34. Riccaboni M, Bianchi I, Petrillo P (2010) Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov Today 15:517-30
35. Richmond A (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2:664-74
36. Sato S, Sanjo H, Takeda K et al. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6:1087-95
37. Sonder SU, Saret S, Tang W et al. (2011) IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J Biol Chem 286:12881-90
38. Sugita S, Kohno T, Yamamoto K et al. (2002) Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J Immunol 168:5621-8
39. Takada Y, Aggarwal BB (2004) TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis. J Immunol 173:1066-77
40. Takaesu G, Kishida S, Hiyama A et al. (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5:649-58
41. Tohyama Y, Yamamura H (2009) Protein tyrosine kinase, syk: a key player in phagocytic cells. J Biochem 145:267-73
42. Turner M, Schweighoffer E, Colucci F et al. (2000) Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today 21:148-54
43. Ulanova M, Marcet-Palacios M, Munoz S et al. (2006) Involvement of Syk kinase in TNF-induced nitric oxide production by airway epithelial cells. Biochem Biophys Res Commun 351:431-7
44. Varesio L, Battaglia F, Raggi F et al. (2010) Macrophage-inflammatory protein-3alpha/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-kappaB. Mol Immunol 47:685-93
45. Waisman A (2012) To be 17 again - anti-interleukin-17 treatment for psoriasis. N Engl J Med 366:1251-2
46. Walsh MC, Kim GK, Maurizio PL et al. (2008) TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL. PLoS One 3:e4064
47. Wu J, Powell F, Larsen NA et al. (2013a) Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. ACS Chem Biol 8: 643-50
48. Wu NL, Huang DY, Hsieh SL et al. (2013b) EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim Biophys Acta 1832:1538-48
49. Wu NL, Lee TA, Tsai TL et al. (2011) TRAIL-induced keratinocyte differentiation requires caspase activation and p63 expression. J Invest Dermatol 131:874-83
50. Zanoni I, Ostuni R, Marek LR et al. (2011) CD14 controls the LPS-induced endocytosis of toll-like receptor 4. Cell 147:868-80
51. Zepp J, Wu L, Li X (2011) IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 32:232-9
52. Zhong B, Liu X, Wang X et al. (2012) Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol 13:1110-7
53. Zhu S, Qian Y (2012) IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci 122:487-511